Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia seen in clinical practice, which places affected patients at an increased risk of mortality, heart failure and thromboembolic events [1,2]. It is a major global burden on the health care system with evidence suggesting an increasing incidence and prevalence [3–5]. A systematic review of world-wide population-based studies (n=184) has revealed that the age-adjusted prevalence and incidence rates of AF have increased in 2010 compared to 1990 [5].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
